CHICAGO - Mondelēz International, Inc. (NASDAQ:MDLZ), a global leader in snacking, has announced the addition of Brian McNamara to its Board of Directors, effective from yesterday.
McNamara, the current CEO of Haleon plc, brings extensive experience in consumer healthcare to the Mondelēz board, having previously led GSK (LON:GSK)'s Consumer Healthcare business before taking the helm at Haleon in May 2022.
With a career that includes senior leadership roles at Novartis AG (SIX:NOVN) and Procter & Gamble (NYSE:PG), McNamara's expertise spans supply chain management, brand marketing, and customer engagement. His appointment to the board is seen as a strategic move to bolster Mondelēz International's consumer products leadership.
Dirk Van de Put, Chairman & CEO of Mondelēz International said, "We are pleased to welcome Brian to our Board. His breadth and depth of expertise in all aspects of consumer products leadership." McNamara also serves on the Board of Directors for the Consumer Goods Forum, further illustrating his broad engagement in the sector.
The appointment increases the size of Mondelēz International's Board to 11 members, with 10 being independent, including McNamara. This move aligns with the company's governance practices and its commitment to independent oversight.
The information for this report is based on a press release statement from Mondelēz International.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.